Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 2001 Jul;91(7):1060–1068. doi: 10.2105/ajph.91.7.1060

HIV in the United States at the turn of the century: an epidemic in transition.

J M Karon 1, P L Fleming 1, R W Steketee 1, K M De Cock 1
PMCID: PMC1446722  PMID: 11441732

Abstract

OBJECTIVES: The current status of and changes in the HIV epidemic in the United States are described. METHODS: Surveillance data were used to evaluate time trends in AIDS diagnoses and deaths. Estimates of HIV incidence were derived from studies done during the 1990s; time trends in recent HIV incidence were inferred from HIV diagnoses and seroprevalence rates among young persons. RESULTS: Numbers of deaths and AIDS diagnoses decreased dramatically during 1996 and 1997 but stabilized or declined only slightly during 1998 and 1999. Proportional decreases were smallest among African American women, women in the South, and persons infected through heterosexual contact, HIV incidence has been roughly constant since 1992 in most populations with time trend data, remains highest among men who have sex with men and injection drug users, and typically is higher among African Americans than other racial/ethnic groups. CONCLUSIONS: The epidemic increasingly affects women minorities, persons infected through heterosexual contact, and the poor. Renewed interest and investment in HIV and AIDS surveillance and surveillance of behaviors associated with HIV transmission are essential to direct resources for prevention to populations with greatest need and to evaluate intervention programs.

Full Text

The Full Text of this article is available as a PDF (154.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen R., Bozzette S., Shapiro M., St Clair P., Morton S., Crystal S., Goldman D., Wenger N., Gifford A., Leibowitz A. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res. 2000 Jun;35(2):389–416. [PMC free article] [PubMed] [Google Scholar]
  2. Biggar R. J. AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters. AIDS. 1990 Nov;4(11):1059–1066. doi: 10.1097/00002030-199011000-00002. [DOI] [PubMed] [Google Scholar]
  3. Buchbinder S. P., Douglas J. M., Jr, McKirnan D. J., Judson F. N., Katz M. H., MacQueen K. M. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis. 1996 Nov;174(5):954–961. doi: 10.1093/infdis/174.5.954. [DOI] [PubMed] [Google Scholar]
  4. Cowan D. N., Brundage J. F., Pomerantz R. S. HIV infection among women in the Army Reserve Components. J Acquir Immune Defic Syndr. 1994 Feb;7(2):171–176. [PubMed] [Google Scholar]
  5. Cowan D. N., Brundage J. F., Pomerantz R. S. The incidence of HIV infection among men in the United States Army Reserve Components, 1985-1991. AIDS. 1994 Apr;8(4):505–511. doi: 10.1097/00002030-199404000-00014. [DOI] [PubMed] [Google Scholar]
  6. Davis S. F., Rosen D. H., Steinberg S., Wortley P. M., Karon J. M., Gwinn M. Trends in HIV prevalence among childbearing women in the United States, 1989-1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):158–164. doi: 10.1097/00042560-199810010-00009. [DOI] [PubMed] [Google Scholar]
  7. Des Jarlais D. C., Marmor M., Friedmann P., Titus S., Aviles E., Deren S., Torian L., Glebatis D., Murrill C., Monterroso E. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000 Mar;90(3):352–359. doi: 10.2105/ajph.90.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diaz T., Chu S. Y., Buehler J. W., Boyd D., Checko P. J., Conti L., Davidson A. J., Hermann P., Herr M., Levy A. Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med. 1994 Jul-Aug;10(4):217–222. [PubMed] [Google Scholar]
  9. Fleming P. L., Ward J. W., Karon J. M., Hanson D. L., De Cock K. M. Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS. 1998;12 (Suppl A):S55–S61. [PubMed] [Google Scholar]
  10. Fleming P. L., Wortley P. M., Karon J. M., DeCock K. M., Janssen R. S. Tracking the HIV epidemic: current issues, future challenges. Am J Public Health. 2000 Jul;90(7):1037–1041. doi: 10.2105/ajph.90.7.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Glynn S. A., Schreiber G. B., Busch M. P., Kleinman S. H., Williams A. E., Nass C. C., Ownby H. E., Smith J. W. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study. Transfusion. 1998 Apr;38(4):350–358. doi: 10.1046/j.1537-2995.1998.38498257373.x. [DOI] [PubMed] [Google Scholar]
  12. Green T. A. Using surveillance data to monitor trends in the AIDS epidemic. Stat Med. 1998 Jan 30;17(2):143–154. doi: 10.1002/(sici)1097-0258(19980130)17:2<143::aid-sim757>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  13. Janssen R. S., Satten G. A., Stramer S. L., Rawal B. D., O'Brien T. R., Weiblen B. J., Hecht F. M., Jack N., Cleghorn F. R., Kahn J. O. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998 Jul 1;280(1):42–48. doi: 10.1001/jama.280.1.42. [DOI] [PubMed] [Google Scholar]
  14. Kerndt P. R., Weber M., Ford W., Prevots D. R., Lehman J. S. HIV incidence among injection drug users enrolled in a Los Angeles methadone program. JAMA. 1995 Jun 21;273(23):1831–1832. doi: 10.1001/jama.1995.03520470039016. [DOI] [PubMed] [Google Scholar]
  15. Koblin B. A., Taylor P. E., Avrett S., Stevens C. E. The feasibility of HIV-1 vaccine efficacy trials among gay/bisexual men in New York City: Project ACHIEVE. AIDS Community Health Initiative Enroute to the Vaccine EFfort. AIDS. 1996 Nov;10(13):1555–1561. doi: 10.1097/00002030-199611000-00015. [DOI] [PubMed] [Google Scholar]
  16. Lindegren M. L., Byers R. H., Jr, Thomas P., Davis S. F., Caldwell B., Rogers M., Gwinn M., Ward J. W., Fleming P. L. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999 Aug 11;282(6):531–538. doi: 10.1001/jama.282.6.531. [DOI] [PubMed] [Google Scholar]
  17. McFarland W., Busch M. P., Kellogg T. A., Rawal B. D., Satten G. A., Katz M. H., Dilley J., Janssen R. S. Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco. J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):484–489. doi: 10.1097/00126334-199912150-00009. [DOI] [PubMed] [Google Scholar]
  18. McNaghten A. D., Hanson D. L., Jones J. L., Dworkin M. S., Ward J. W. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS. 1999 Sep 10;13(13):1687–1695. doi: 10.1097/00002030-199909100-00012. [DOI] [PubMed] [Google Scholar]
  19. Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993 Sep;6(9):1049–1056. [PubMed] [Google Scholar]
  20. Meyers K., Metzger D. S., McLellan A. T., Navaline H., Sheon A. R., Woody G. E. Will preventive HIV vaccine efficacy trials be possible with female injection drug users? J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):577–585. [PubMed] [Google Scholar]
  21. Murrill C. S., Prevots D. R., Miller M. S., Linley L. A., Royalty J. E., Gwinn M., Seroincidence Study Group Incidence of HIV among injection drug users entering drug treatment programs in four US cities. J Urban Health. 2001 Mar;78(1):152–161. doi: 10.1093/jurban/78.1.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  23. Renzullo P. O., McNeil J. G., Wann Z. F., Burke D. S., Brundage J. F. Human immunodeficiency virus type-1 seroconversion trends among young adults serving in the United States Army, 1985-1993. United States Military Medical Consortium for Applied Retroviral Research. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):177–185. doi: 10.1097/00042560-199510020-00011. [DOI] [PubMed] [Google Scholar]
  24. Rosenberg P. S., Biggar R. J. Trends in HIV incidence among young adults in the United States. JAMA. 1998 Jun 17;279(23):1894–1899. doi: 10.1001/jama.279.23.1894. [DOI] [PubMed] [Google Scholar]
  25. Rosenberg P. S. Scope of the AIDS epidemic in the United States. Science. 1995 Nov 24;270(5240):1372–1375. doi: 10.1126/science.270.5240.1372. [DOI] [PubMed] [Google Scholar]
  26. Schwarcz S., Kellogg T., McFarland W., Louie B., Kohn R., Busch M., Katz M., Bolan G., Klausner J., Weinstock H. Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion. Am J Epidemiol. 2001 May 15;153(10):925–934. doi: 10.1093/aje/153.10.925. [DOI] [PubMed] [Google Scholar]
  27. Shapiro M. F., Morton S. C., McCaffrey D. F., Senterfitt J. W., Fleishman J. A., Perlman J. F., Athey L. A., Keesey J. W., Goldman D. P., Berry S. H. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999 Jun 23;281(24):2305–2315. doi: 10.1001/jama.281.24.2305. [DOI] [PubMed] [Google Scholar]
  28. Simon P. A., Hu D. J., Diaz T., Kerndt P. R. Income and AIDS rates in Los Angeles County. AIDS. 1995 Mar;9(3):281–284. [PubMed] [Google Scholar]
  29. Tabet S. R., Krone M. R., Paradise M. A., Corey L., Stamm W. E., Celum C. L. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS. 1998 Oct 22;12(15):2041–2048. doi: 10.1097/00002030-199815000-00016. [DOI] [PubMed] [Google Scholar]
  30. Valleroy L. A., MacKellar D. A., Karon J. M., Janssen R. S., Hayman C. R. HIV infection in disadvantaged out-of-school youth: prevalence for U.S. Job Corps entrants, 1990 through 1996. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):67–73. doi: 10.1097/00042560-199809010-00011. [DOI] [PubMed] [Google Scholar]
  31. Valleroy L. A., MacKellar D. A., Karon J. M., Rosen D. H., McFarland W., Shehan D. A., Stoyanoff S. R., LaLota M., Celentano D. D., Koblin B. A. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA. 2000 Jul 12;284(2):198–204. doi: 10.1001/jama.284.2.198. [DOI] [PubMed] [Google Scholar]
  32. Weinstock H., Sweeney S., Satten G. A., Gwinn M. HIV seroincidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. STD Clinic HIV Seroincidence Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):506–512. doi: 10.1097/00042560-199812150-00010. [DOI] [PubMed] [Google Scholar]
  33. Wortley P. M., Chu S. Y., Diaz T., Ward J. W., Doyle B., Davidson A. J., Checko P. J., Herr M., Conti L., Fann S. A. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS. 1995 May;9(5):487–492. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES